1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	403_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	403_QUEST_clinical_caseMIR	SENT1	-	-
3	65	65		-	-	9-11	403_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	403_QUEST_clinical_caseMIR	SENT1	-	-
5	de	de	SPS00	C0001779_1	entidad_observable_1	17-19	403_QUEST_clinical_caseMIR	SENT1	-	-
6	edad	edad	NCFS000	C0001779_2	entidad_observable_2	20-24	403_QUEST_clinical_caseMIR	SENT1	-	-
7	obesa	obeso	AQ0FS0	C0028754	hallazgo	25-30	403_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
8	,	,	Fc	-	-	30-31	403_QUEST_clinical_caseMIR	SENT1	-	-
9	hipertensa	hipertenso	AQ0FS0	-	-	32-42	403_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
10	y	y	CC	C1706368	calificador	43-44	403_QUEST_clinical_caseMIR	SENT1	-	-
11	con	con	SPS00	C0332287	atributo	45-48	403_QUEST_clinical_caseMIR	SENT1	-	-
12	nefropatía	nefropatía	NCFS000	C0011881_1	trastorno_1	49-59	403_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	diabética	diabético	NCFS000	C0011881_2	trastorno_2	60-69	403_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
14	(	(	Fpa	-	-	70-71	403_QUEST_clinical_caseMIR	SENT1	-	-
15	filtrado	filtrado	NCMS000	-	-	71-79	403_QUEST_clinical_caseMIR	SENT1	-	-
16	glomerular	glomerular	AQ0CS0	-	-	80-90	403_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
17	estimado	estimar	VMP00SM	-	-	91-99	403_QUEST_clinical_caseMIR	SENT1	-	-
18	de	de	SPS00	C0332285	atributo	100-102	403_QUEST_clinical_caseMIR	SENT1	-	-
19	38	38		-	-	103-105	403_QUEST_clinical_caseMIR	SENT1	-	-
20	mL/min/1,73	mL/min/1,73	Z	-	-	106-117	403_QUEST_clinical_caseMIR	SENT1	-	-
21	m2	m2	NCMP000	-	-	118-120	403_QUEST_clinical_caseMIR	SENT1	-	-
22	y	y	CC	C1706368	calificador	121-122	403_QUEST_clinical_caseMIR	SENT1	-	-
23	albuminuria	albuminuria	NCFS000	C0001925#C0033687	hallazgo	123-134	403_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
24	de	de	SPS00	C0332285	atributo	135-137	403_QUEST_clinical_caseMIR	SENT1	-	-
25	420	420	Z	-	-	138-141	403_QUEST_clinical_caseMIR	SENT1	-	-
26	mg	mg	NCMN000	-	-	142-144	403_QUEST_clinical_caseMIR	SENT1	-	-
27	en	en	SPS00	C1720294#C0332285	calificador#atributo	145-147	403_QUEST_clinical_caseMIR	SENT1	-	-
28	orina	orina	NCFS000	C0042036	sustancia	148-153	403_QUEST_clinical_caseMIR	SENT1	-	-
29	de	de	SPS00	C0332285	atributo	154-156	403_QUEST_clinical_caseMIR	SENT1	-	-
30	24	24	Z	-	-	157-159	403_QUEST_clinical_caseMIR	SENT1	-	-
31	h	h	NCMN000	C0439227	calificador	160-161	403_QUEST_clinical_caseMIR	SENT1	-	-
32	)	)	Fpt	-	-	161-162	403_QUEST_clinical_caseMIR	SENT1	-	-
33	.	.	Fp	-	-	162-163	403_QUEST_clinical_caseMIR	SENT1	-	-

1	¿	¿	Fia	-	-	164-165	403_QUEST_clinical_caseMIR	SENT2	-	-
2	Cuál	cuál	PT0CS000	-	-	165-169	403_QUEST_clinical_caseMIR	SENT2	-	-
3	de	de	SPS00	C0332285	atributo	170-172	403_QUEST_clinical_caseMIR	SENT2	-	-
4	los	el	DA0MP0	-	-	173-176	403_QUEST_clinical_caseMIR	SENT2	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	177-187	403_QUEST_clinical_caseMIR	SENT2	-	-
6	NO	no	RN	C1298908	calificador	188-190	403_QUEST_clinical_caseMIR	SENT2	-	-
7	es	ser	VSIP3S0	-	-	191-193	403_QUEST_clinical_caseMIR	SENT2	-	-
8	un	un		C0205447_1	calificador_1	194-196	403_QUEST_clinical_caseMIR	SENT2	-	-
9	factor	factor	NCMS000	-	-	197-203	403_QUEST_clinical_caseMIR	SENT2	-	-
10	de	de	SPS00	C0332285	atributo	204-206	403_QUEST_clinical_caseMIR	SENT2	-	-
11	progresión	progresión	NCFS000	C0449258	atributo	207-217	403_QUEST_clinical_caseMIR	SENT2	-	-
12	de	de	SPS00	C0332285	atributo	218-220	403_QUEST_clinical_caseMIR	SENT2	-	-
13	la	el	DA0FS0	-	-	221-223	403_QUEST_clinical_caseMIR	SENT2	-	-
14	nefropatía	nefropatía	NCFS000	C0022658#C0027720	trastorno	224-234	403_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
15	?	?	Fit	-	-	234-235	403_QUEST_clinical_caseMIR	SENT2	-	-

